Amicus Therapeutics Inc (FOLD) Insider Trading
- $71,123,425.77
- $145,122,652.45
- Nov. 6, 2024
- John F Crowley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 6, 2024 | CEO | 7,901 | $12.50 | Sell | $98,762.50 | |
Nov. 1, 2024 | CEO | 7,500 | $11.46 | Sell | $85,950.00 | |
Oct. 1, 2024 | CEO | 7,500 | $10.60 | Sell | $79,500.00 | |
Sept. 3, 2024 | CEO | 7,500 | $11.71 | Sell | $87,825.00 | |
Aug. 1, 2024 | CEO | 7,500 | $10.34 | Sell | $77,550.00 | |
July 5, 2024 | CEO | 6,100 | $10.00 | Sell | $61,000.00 | |
May 1, 2024 | CEO | 7,500 | $10.07 | Sell | $75,525.00 | |
March 5, 2024 | Director | 7,500 | $13.40 | Sell | $100,500.00 | |
Feb. 15, 2024 | Insider | 4,427 | $14.00 | Sell | $61,978.00 | |
Feb. 15, 2024 | CEO | 4,167 | $14.00 | Sell | $58,338.00 | |
Feb. 15, 2024 | Chairman | 31,614 | $13.81 | Sell | $436,589.34 | |
Feb. 6, 2024 | Insider | 400 | $13.00 | Sell | $5,200.00 | |
Jan. 22, 2024 | Chairman | 55,327 | $12.36 | Sell | $683,841.72 | |
Jan. 16, 2024 | Chairman | 31,614 | $12.78 | Sell | $404,026.92 | |
Jan. 10, 2024 | Chairman | 31,614 | $13.65 | Sell | $431,531.10 | |
Jan. 9, 2024 | Insider | 1,384 | $14.00 | Sell | $19,376.00 | |
Jan. 8, 2024 | CAO | 30,767 | $14.00 | Sell | $430,738.00 | |
Jan. 2, 2024 | CEO | 15,833 | $14.23 | Sell | $225,303.59 | |
Jan. 2, 2024 | Insider | 30,000 | $14.21 | Sell | $426,300.00 | |
Dec. 27, 2023 | Insider | 5,000 | $14.07 | Sell | $70,350.00 | |
Dec. 26, 2023 | CAO | 7,659 | $14.00 | Sell | $107,226.00 | |
Dec. 19, 2023 | Insider | 17,500 | $13.25 | Sell | $231,875.00 | |
Dec. 15, 2023 | Chairman | 6,043 | $12.66 | Sell | $76,504.38 | |
Dec. 1, 2023 | Chairman | 6,043 | $11.08 | Sell | $66,956.44 | |
Dec. 1, 2023 | CEO | 11,702 | $11.08 | Sell | $129,658.16 | |
Nov. 15, 2023 | Chairman | 6,043 | $10.84 | Sell | $65,506.12 | |
Nov. 1, 2023 | CEO | 11,700 | $10.97 | Sell | $128,349.00 | |
Nov. 1, 2023 | Chairman | 6,044 | $10.97 | Sell | $66,302.68 | |
Oct. 16, 2023 | Chairman | 6,044 | $10.50 | Sell | $63,462.00 | |
Oct. 2, 2023 | Chairman | 6,044 | $11.25 | Sell | $67,995.00 | |
Oct. 2, 2023 | CEO | 11,700 | $11.24 | Sell | $131,508.00 | |
Sept. 15, 2023 | Chairman | 6,044 | $13.06 | Sell | $78,934.64 | |
Sept. 1, 2023 | CEO | 18,093 | $12.97 | Sell | $234,666.21 | |
Sept. 1, 2023 | Chairman | 6,044 | $12.98 | Sell | $78,451.12 | |
Aug. 15, 2023 | Chairman | 6,044 | $13.03 | Sell | $78,753.32 | |
Aug. 9, 2023 | CAO | 36,909 | $14.01 | Sell | $517,095.09 | |
Aug. 1, 2023 | Chairman | 6,044 | $13.35 | Sell | $80,687.40 | |
Aug. 1, 2023 | CEO | 20,000 | $13.39 | Sell | $267,800.00 | |
July 17, 2023 | Chairman | 6,044 | $13.45 | Sell | $81,291.80 | |
July 12, 2023 | CEO | 1,500 | $12.51 | Sell | $18,765.00 | |
July 3, 2023 | Chairman | 6,044 | $12.31 | Sell | $74,401.64 | |
July 3, 2023 | CEO | 11,700 | $12.31 | Sell | $144,027.00 | |
June 15, 2023 | Chairman | 6,044 | $13.04 | Sell | $78,813.76 | |
June 6, 2023 | CEO | 8,300 | $12.50 | Sell | $103,750.00 | |
June 1, 2023 | Chairman | 6,044 | $11.36 | Sell | $68,659.84 | |
June 1, 2023 | CEO | 11,700 | $11.36 | Sell | $132,912.00 | |
May 15, 2023 | Chairman | 6,044 | $11.18 | Sell | $67,571.92 | |
May 1, 2023 | Chairman | 6,044 | $11.80 | Sell | $71,319.20 | |
May 1, 2023 | CEO | 11,700 | $11.80 | Sell | $138,060.00 | |
April 17, 2023 | Chairman | 6,044 | $11.66 | Sell | $70,473.04 |
Insiders are both buying and selling Amicus Therapeutics Inc stock.
The insider traders at Amicus Therapeutics Inc are: John F Crowley, Bradley L Campbell, Jay Barth, Hung Do, Burke W Whitman, Daphne Quimi, William D Baird III, Perceptive Advisors Llc, Ellen Rosenberg, Jeff Castelli, Samantha Prout, Margaret G Mcglynn, Michael Raab, David Michael Clark, Life Sciences Maste Perceptive, Kenneth Peist, Jayne Gershkowitz, Glenn Sblendorio, Julie Yu, Donald J Hayden Jr, Kurt J Andrews, Plc Glaxosmithkline, Ken Valenzano, Bradley L. Campbell, Enrique Dilone, William D. Baird III, Burke W. Whitman, Dipal Doshi, Joan Winterbottom, John F. Crowley, Lynn Dorsey Bleil, and Sol J Barer
The most active insider trader at Amicus Therapeutics Inc is John F Crowley with 110 trades.
Plc Glaxosmithkline has sold the most Amicus Therapeutics Inc stock with a total value of $119,721,428.50.
Perceptive Advisors Llc has bought the most Amicus Therapeutics Inc stock with a total value of $40,474,740.62.
The most recent insider trade for Amicus Therapeutics Inc was on Nov. 6, 2024.
The single biggest insider buy for Amicus Therapeutics Inc was from Life Sciences Maste Perceptive with a total value of $18,375,000.00 on July 13, 2017.
The single biggest insider sell for Amicus Therapeutics Inc was from Plc Glaxosmithkline with a total value of $59,860,714.25 on Oct. 27, 2014.